Effect of Fetuin A in Hemodialysis Patients
The Effect of Serum Fetuin A Concentration on the 5-Year Prognosis in Hemodialysis Patients
1 other identifier
observational
300
1 country
1
Brief Summary
The purpose of this study is to examined the effect of fetuin A on atherosclerosis and prognosis in hemodialysis patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2001
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2006
CompletedFirst Submitted
Initial submission to the registry
March 27, 2006
CompletedFirst Posted
Study publicly available on registry
March 31, 2006
CompletedMay 22, 2006
March 1, 2006
March 27, 2006
May 18, 2006
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Hemodialysis for at least 6 months
You may not qualify if:
- Disabled patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Shizuokalead
- Maruyama Memorial General Hospitalcollaborator
Study Sites (1)
Maruyama Hospital
Hamamatsu, Shizuoka, 430-0001, Japan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hiromichi Kumagai, MD
University of Shizuoka
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
March 27, 2006
First Posted
March 31, 2006
Study Start
March 1, 2001
Study Completion
March 1, 2006
Last Updated
May 22, 2006
Record last verified: 2006-03